CCT196969 is primarily utilized in research settings as a potent and selective inhibitor of the protein kinase C-Raf. This makes it a valuable tool in studying cellular signaling pathways, particularly those involving the MAPK/ERK pathway, which plays a critical role in cell proliferation, differentiation, and survival. Researchers employ CCT196969 to investigate the mechanisms of cancer development and progression, as C-Raf is often implicated in various cancers. Additionally, it is used to explore potential therapeutic strategies by targeting Raf kinases, which are key components in oncogenic signaling. Its application extends to preclinical studies where it helps in understanding the efficacy and specificity of kinase inhibitors in treating malignancies.